Cargando…

A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort

Background. Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC). The aim of this study is to assess the yield of surveillance colonoscopies in a tertiary referral cohort of ulcerative colitis patients and to identify different risk groups for dysplasia. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolwijk, J. A. M., Langers, A. M. J., Hardwick, J. C., Veenendaal, R. A., Verspaget, H. W., van Hogezand, R. A., Vasen, H. F., van der Meulen-de Jong, A. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863532/
https://www.ncbi.nlm.nih.gov/pubmed/24379739
http://dx.doi.org/10.1155/2013/274715
_version_ 1782295831960879104
author Stolwijk, J. A. M.
Langers, A. M. J.
Hardwick, J. C.
Veenendaal, R. A.
Verspaget, H. W.
van Hogezand, R. A.
Vasen, H. F.
van der Meulen-de Jong, A. E.
author_facet Stolwijk, J. A. M.
Langers, A. M. J.
Hardwick, J. C.
Veenendaal, R. A.
Verspaget, H. W.
van Hogezand, R. A.
Vasen, H. F.
van der Meulen-de Jong, A. E.
author_sort Stolwijk, J. A. M.
collection PubMed
description Background. Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC). The aim of this study is to assess the yield of surveillance colonoscopies in a tertiary referral cohort of ulcerative colitis patients and to identify different risk groups for dysplasia. Methods. A cohort of 293 patients (148 males, mean age 33.8 years at diagnosis) was built up at our center and started the surveillance program 8–12 years after start of symptoms. They underwent colonoscopies every one to three years. Endpoints were dysplasia or a (sub)total colectomy. Results. After a follow-up period of 10 years, the cumulative incidence of any dysplasia was 23.5%, and of CRC 4.0%. After 15 years these percentages were 33.3% and 6.8%. Patients with pancolitis (n = 178) had a significantly higher cumulative risk of dysplasia than patients with distal disease, HR 1.9 (95%CI 1.1–3.3). Patients who started surveillance at an older age are at increased risk for any dysplasia, HR 1.03 (95%CI 1.01–1.05). Conclusions. This prospective surveillance study shows a high yield of dysplasia in ulcerative colitis patients. We recommend developing separate surveillance programs for different risk groups. In our opinion patients with distal colitis can follow the general population surveillance program.
format Online
Article
Text
id pubmed-3863532
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38635322013-12-30 A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort Stolwijk, J. A. M. Langers, A. M. J. Hardwick, J. C. Veenendaal, R. A. Verspaget, H. W. van Hogezand, R. A. Vasen, H. F. van der Meulen-de Jong, A. E. ScientificWorldJournal Clinical Study Background. Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC). The aim of this study is to assess the yield of surveillance colonoscopies in a tertiary referral cohort of ulcerative colitis patients and to identify different risk groups for dysplasia. Methods. A cohort of 293 patients (148 males, mean age 33.8 years at diagnosis) was built up at our center and started the surveillance program 8–12 years after start of symptoms. They underwent colonoscopies every one to three years. Endpoints were dysplasia or a (sub)total colectomy. Results. After a follow-up period of 10 years, the cumulative incidence of any dysplasia was 23.5%, and of CRC 4.0%. After 15 years these percentages were 33.3% and 6.8%. Patients with pancolitis (n = 178) had a significantly higher cumulative risk of dysplasia than patients with distal disease, HR 1.9 (95%CI 1.1–3.3). Patients who started surveillance at an older age are at increased risk for any dysplasia, HR 1.03 (95%CI 1.01–1.05). Conclusions. This prospective surveillance study shows a high yield of dysplasia in ulcerative colitis patients. We recommend developing separate surveillance programs for different risk groups. In our opinion patients with distal colitis can follow the general population surveillance program. Hindawi Publishing Corporation 2013-11-28 /pmc/articles/PMC3863532/ /pubmed/24379739 http://dx.doi.org/10.1155/2013/274715 Text en Copyright © 2013 J. A. M. Stolwijk et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Stolwijk, J. A. M.
Langers, A. M. J.
Hardwick, J. C.
Veenendaal, R. A.
Verspaget, H. W.
van Hogezand, R. A.
Vasen, H. F.
van der Meulen-de Jong, A. E.
A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
title A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
title_full A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
title_fullStr A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
title_full_unstemmed A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
title_short A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort
title_sort thirty-year follow-up surveillance study for neoplasia of a dutch ulcerative colitis cohort
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863532/
https://www.ncbi.nlm.nih.gov/pubmed/24379739
http://dx.doi.org/10.1155/2013/274715
work_keys_str_mv AT stolwijkjam athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT langersamj athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT hardwickjc athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT veenendaalra athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT verspagethw athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT vanhogezandra athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT vasenhf athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT vandermeulendejongae athirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT stolwijkjam thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT langersamj thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT hardwickjc thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT veenendaalra thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT verspagethw thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT vanhogezandra thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT vasenhf thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort
AT vandermeulendejongae thirtyyearfollowupsurveillancestudyforneoplasiaofadutchulcerativecolitiscohort